COMPARATIVE ANTIOXIDANT ACTIVITIES OF PROPRANOLOL, NIFEDIPINE, VERAPAMIL, AND DILTIAZEM AGAINST SARCOLEMMAL MEMBRANE LIPID-PEROXIDATION

被引:170
作者
MAK, IT
WEGLICKI, WB
机构
[1] Div. of Experimental Medicine, George Washington University, Medical Center, Washington, DC 20037, 2300 Eye Street, NW
关键词
antiperoxidant activity; calcium-channel blockers; propranolol; sarcolemmal lipid peroxidation;
D O I
10.1161/01.RES.66.5.1449
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The antiperoxidative activities of nifedipine, verapamil, and diltiazem were compared with that of propranolol by using an in vitro model of sarcolemmal membrane lipid peroxidation. Highly purified sarcolemmal membranes, isolated from canine ventricular myocytes, were peroxidized by a superoxide anion-producing and iron-catalyzed free radical-generating system (dihydroxy-fumarate plus FeCl3 and ADP). Lipid peroxidation after 20 minutes of incubation was monitored by malondialdehyde formation. Similar to propranolol, all three calcium blockers exhibited concentration-dependent (10-400 μM) inhibitory effects against sarcolemmal lipid peroxidation. The order of potency of these agents was nifedipine > propranolol > verapamil > diltiazem. Nifedipine, the most effective calcium blocker, was greater than twofold more potent than propranolol and achieved a significant effect at 10 μM. This study suggests that calcium blockers may provide antiperoxidative protection to cardiac membranes.
引用
收藏
页码:1449 / 1452
页数:4
相关论文
共 22 条
[11]   SPIN-TRAPPING EVIDENCE THAT GRADED MYOCARDIAL-ISCHEMIA ALTERS POSTISCHEMIC SUPEROXIDE PRODUCTION [J].
KRAMER, JH ;
ARROYO, CM .
FREE RADICAL BIOLOGY AND MEDICINE, 1987, 3 (02) :153-159
[12]   DIFFERENTIAL SENSITIVITY OF CANINE CARDIAC SARCOLEMMAL AND MICROSOMAL-ENZYMES TO INHIBITION BY FREE RADICAL-INDUCED LIPID-PEROXIDATION [J].
KRAMER, JH ;
MAK, IT ;
WEGLICKI, WB .
CIRCULATION RESEARCH, 1984, 55 (01) :120-124
[13]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[14]   INHIBITION OF SARCOLEMMAL CARBON-CENTERED FREE-RADICAL FORMATION BY PROPRANOLOL [J].
MAK, IT ;
ARROYO, CM ;
WEGLICKI, WB .
CIRCULATION RESEARCH, 1989, 65 (04) :1151-1156
[15]   PROTECTION BY BETA-BLOCKING-AGENTS AGAINST FREE RADICAL-MEDIATED SARCOLEMMAL LIPID-PEROXIDATION [J].
MAK, IT ;
WEGLICKI, WB .
CIRCULATION RESEARCH, 1988, 63 (01) :262-266
[16]  
MAK IT, 1983, J BIOL CHEM, V258, P3733
[17]  
MCCORD JM, 1985, NEW ENGL J MED, V312, P159
[18]   THE ROLE OF LIPID-PEROXIDATION IN PATHOGENESIS OF ISCHEMIC DAMAGE AND THE ANTIOXIDANT PROTECTION OF THE HEART [J].
MEERSON, FZ ;
KAGAN, VE ;
KOZLOV, YP ;
BELKINA, LM ;
ARKHIPENKO, YV .
BASIC RESEARCH IN CARDIOLOGY, 1982, 77 (05) :465-485
[19]   PROTECTIVE EFFECT OF PRETREATMENT WITH VERAPAMIL, NIFEDIPINE AND PROPRANOLOL ON MITOCHONDRIAL-FUNCTION IN THE ISCHEMIC AND REPERFUSED MYOCARDIUM [J].
NAYLER, WG ;
FERRARI, R ;
WILLIAMS, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1980, 46 (02) :242-248
[20]   UPTAKE OF CALCIUM ANTAGONISTIC DRUGS INTO MUSCLES AS RELATED TO THEIR LIPID SOLUBILITIES [J].
PANG, DC ;
SPERELAKIS, N .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (05) :821-826